Dabrafenib Mesylate

Catalog No. A15059

Dabrafenib Mesylate是一种新颖,有效和选择性的Raf激酶抑制剂,能够抑制野生型B-Raf,B-RafV600E和c-Raf的激酶活性,IC50值分别为3.2、0.8和5.0 nM。
Catalog Num A15059
M. Wt 615.67
Formula C24H24F3N5O5S3
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 1195768-06-9
Synonyms GSK-2118436 Mesylate, GSK2118436 Mesylate, GSK 2118436 Mesylate, GSK 2118436B
SMILES CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F.CS(=O)(=O)O
Dabrafenib Mesylate是一种新颖,有效和选择性的Raf激酶抑制剂,能够抑制野生型B-Raf,B-RafV600E和c-Raf的激酶活性,IC50值分别为3.2、0.8和5.0 nM。
In vitro DMSO 96 mg/mL (155.92 mM)
Water Insoluble
Ethanol 5 mg/mL (8.12 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 16.24 mL 81.21 mL 162.42 mL
0.5 mM 3.25 mL 16.24 mL 32.48 mL
1 mM 1.62 mL 8.12 mL 16.24 mL
5 mM 0.32 mL 1.62 mL 3.25 mL

*The above data is based on the productmolecular weight 615.67. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.